CSIMarket
 


Pluristem Therapeutics Inc   (PSTI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Pluristem Therapeutics Inc 's Working Capital Ratio

PSTI's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




PSTI Working Capital Ratio (Jun 30 2020)
IV. Quarter
(Mar 31 2020)
III. Quarter
(Dec 31 2019)
II. Quarter
(Sep 30 2019)
I. Quarter
(Jun 30 2019)
IV. Quarter
Y / Y Current Liabilities Change -2.1 % -24.6 % -16.69 % -7.02 % -4.56 %
Y / Y Current Assets Change 83.77 % 35.03 % 4.76 % -12.19 % -17.68 %
Working Capital Ratio MRQ 6.07 2.87 3.19 3.12 3.23
Overall Ranking # # # # #
Seq. Current Liabilities Change 28.45 % 3.17 % -12.39 % -15.68 % -1.08 %
Seq. Current Assets Change 171.96 % -7.32 % -10.45 % -18.58 % 99.84 %



Working Capital Ratio forth quarter 2020 Comment
Pluristem Therapeutics Inc 's Current Assets grew by 171.96 % in IV. Quarter sequntially, faster than Current Liabilities, this led to improvement in Pluristem Therapeutics Inc 's Working Capital Ratio to 6.07, Working Capital Ratio remained below Pluristem Therapeutics Inc average.

Within Biotechnology & Drugs industry 93 other companies have achieved higher Working Capital Ratio than Pluristem Therapeutics Inc in forth quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is PSTI most successful ?
Working Capital Ratio PSTI on the trailing twelve month basis
Working Capital Ratio forth quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 94
Healthcare Sector # 302
Overall Market # 764


Working Capital Ratio Statistics
High Average Low
13.38 7.01 1.6
(Sep 30 2012)   (Mar 31 2019)




Financial Statements
Pluristem Therapeutics Inc 's Current Liabilities $ 8 Millions Visit PSTI's Balance sheet
Pluristem Therapeutics Inc 's Current Assets $ 48 Millions Visit PSTI's Balance sheet
Source of PSTI's Sales Visit PSTI's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingJun 30 2020, within Biotechnology & Drugs Industry Working Capital RatioJun 30 2020 MRQ Current AssetsJun 30 2020 MRQ Current Liabilities
Iovance Biotherapeutics inc   15.96 $ 782.654  Millions$ 49.032  Millions
Syndax Pharmaceuticals Inc   15.39 $ 191.807  Millions$ 12.467  Millions
Satsuma Pharmaceuticals Inc   15.11 $ 100.738  Millions$ 6.665  Millions
Diffusion Pharmaceuticals Inc   14.99 $ 26.709  Millions$ 1.782  Millions
Immunovant Inc   14.64 $ 286.116  Millions$ 19.544  Millions
Aerpio Pharmaceuticals Inc   14.63 $ 45.435  Millions$ 3.105  Millions
Enzon Pharmaceuticals Inc   14.06 $ 6.004  Millions$ 0.427  Millions
Pdl Biopharma Inc   13.68 $ 495.548  Millions$ 36.235  Millions
Renovacare Inc   13.37 $ 10.662  Millions$ 0.797  Millions
Casi Pharmaceuticals Inc   13.35 $ 55.780  Millions$ 4.179  Millions
Adverum Biotechnologies Inc   13.30 $ 282.681  Millions$ 21.254  Millions
Crispr Therapeutics Ag  12.96 $ 965.618  Millions$ 74.505  Millions
Riot Blockchain Inc   12.93 $ 17.210  Millions$ 1.331  Millions
Timber Pharmaceuticals Inc   12.31 $ 13.800  Millions$ 1.121  Millions
Fennec Pharmaceuticals Inc   12.19 $ 38.899  Millions$ 3.190  Millions
Acceleron Pharma inc  12.02 $ 448.950  Millions$ 37.360  Millions
Checkmate Pharmaceuticals Inc   11.95 $ 83.456  Millions$ 6.985  Millions
Fate Therapeutics Inc  11.92 $ 540.225  Millions$ 45.322  Millions
Adaptimmune Therapeutics Plc  11.88 $ 458.087  Millions$ 38.559  Millions
Arcus Biosciences Inc   11.78 $ 471.599  Millions$ 40.025  Millions
Eidos Therapeutics Inc   11.62 $ 178.793  Millions$ 15.389  Millions
Xenetic Biosciences Inc   11.58 $ 9.116  Millions$ 0.787  Millions
Atara Biotherapeutics Inc   11.33 $ 358.987  Millions$ 31.684  Millions
Axcella Health Inc   11.31 $ 124.191  Millions$ 10.981  Millions
Surface Oncology Inc   11.12 $ 117.580  Millions$ 10.577  Millions
Adma Biologics Inc   11.10 $ 142.990  Millions$ 12.880  Millions
89bio Inc   11.09 $ 75.291  Millions$ 6.791  Millions
Neogen Corp  11.08 $ 537.406  Millions$ 48.489  Millions
G1 Therapeutics Inc   10.95 $ 240.091  Millions$ 21.924  Millions
Coherus Biosciences inc   10.64 $ 675.860  Millions$ 63.534  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AFAI's Profile

Stock Price

AFAI's Financials

Business Description

Fundamentals

Charts & Quotes

AFAI's News

Suppliers

AFAI's Competitors

Customers & Markets

Economic Indicators

AFAI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071